SEM4A_HUMAN
ID SEM4A_HUMAN Reviewed; 761 AA.
AC Q9H3S1; B2RDH8; B3KR76; Q5TCI5; Q5TCJ6; Q8WUA9;
DT 02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT 11-APR-2003, sequence version 2.
DT 03-AUG-2022, entry version 186.
DE RecName: Full=Semaphorin-4A;
DE AltName: Full=Semaphorin-B;
DE Short=Sema B;
DE Flags: Precursor;
GN Name=SEMA4A; Synonyms=SEMAB, SEMB; ORFNames=UNQ783/PRO1317;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA Seki N., Hattori A., Hayashi A., Kozuma S., Muramatsu M., Miyajima N.,
RA Saito T.;
RT "Human semaphorin B.";
RL Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX PubMed=12975309; DOI=10.1101/gr.1293003;
RA Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT identify novel human secreted and transmembrane proteins: a bioinformatics
RT assessment.";
RL Genome Res. 13:2265-2270(2003).
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC TISSUE=Placenta, and Tongue;
RX PubMed=14702039; DOI=10.1038/ng1285;
RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA Isogai T., Sugano S.;
RT "Complete sequencing and characterization of 21,243 full-length human
RT cDNAs.";
RL Nat. Genet. 36:40-45(2004).
RN [4]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=16710414; DOI=10.1038/nature04727;
RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT "The DNA sequence and biological annotation of human chromosome 1.";
RL Nature 441:315-321(2006).
RN [5]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC TISSUE=Colon;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [6]
RP SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANT GLN-713, AND
RP CHARACTERIZATION OF VARIANTS RP35 HIS-345 AND CYS-350.
RX PubMed=22956603; DOI=10.1167/iovs.11-9378;
RA Tsuruma K., Nishimura Y., Kishi S., Shimazawa M., Tanaka T., Hara H.;
RT "SEMA4A mutations lead to susceptibility to light irradiation, oxidative
RT stress, and ER stress in retinal pigment epithelial cells.";
RL Invest. Ophthalmol. Vis. Sci. 53:6729-6737(2012).
RN [7]
RP VARIANTS RP35 HIS-345 AND CYS-350, VARIANTS CORD10 HIS-345 AND CYS-350, AND
RP VARIANT GLN-713.
RX PubMed=16199541; DOI=10.1136/jmg.2005.035055;
RA Abid A., Ismail M., Mehdi S.Q., Khaliq S.;
RT "Identification of novel mutations in the SEMA4A gene associated with
RT retinal degenerative diseases.";
RL J. Med. Genet. 43:378-381(2006).
RN [8]
RP VARIANT GLN-713.
RX PubMed=28805479; DOI=10.1080/13816810.2017.1354384;
RA Bryant L., Lozynska O., Han G., Morgan J.I.W., Gai X., Maguire A.M.,
RA Aleman T., Bennett J.;
RT "On variants and disease-causing mutations: Case studies of a SEMA4A
RT variant identified in inherited blindness.";
RL Ophthalmic Genet. 39:144-146(2018).
CC -!- FUNCTION: Cell surface receptor for PLXNB1, PLXNB2, PLXNB3 and PLXND1
CC that plays an important role in cell-cell signaling (By similarity).
CC Regulates glutamatergic and GABAergic synapse development (By
CC similarity). Promotes the development of inhibitory synapses in a
CC PLXNB1-dependent manner and promotes the development of excitatory
CC synapses in a PLXNB2-dependent manner (By similarity). Plays a role in
CC priming antigen-specific T-cells, promotes differentiation of Th1 T-
CC helper cells, and thereby contributes to adaptive immunity (By
CC similarity). Promotes phosphorylation of TIMD2 (By similarity).
CC Inhibits angiogenesis (By similarity). Promotes axon growth cone
CC collapse (By similarity). Inhibits axonal extension by providing local
CC signals to specify territories inaccessible for growing axons (By
CC similarity). {ECO:0000250|UniProtKB:Q62178}.
CC -!- SUBUNIT: Interacts with PLXNB1, PLXNB2, PLXNB3, PLXND1 and TIMD2 (By
CC similarity). {ECO:0000250|UniProtKB:Q62178}.
CC -!- INTERACTION:
CC Q9H3S1; Q9Y4D7: PLXND1; NbExp=2; IntAct=EBI-3924922, EBI-310731;
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22956603};
CC Single-pass type I membrane protein {ECO:0000255}.
CC -!- ALTERNATIVE PRODUCTS:
CC Event=Alternative splicing; Named isoforms=2;
CC Name=1;
CC IsoId=Q9H3S1-1; Sequence=Displayed;
CC Name=2;
CC IsoId=Q9H3S1-2; Sequence=VSP_046381, VSP_046382;
CC -!- DISEASE: Retinitis pigmentosa 35 (RP35) [MIM:610282]: A retinal
CC dystrophy belonging to the group of pigmentary retinopathies. Retinitis
CC pigmentosa is characterized by retinal pigment deposits visible on
CC fundus examination and primary loss of rod photoreceptor cells followed
CC by secondary loss of cone photoreceptors. Patients typically have night
CC vision blindness and loss of midperipheral visual field. As their
CC condition progresses, they lose their far peripheral visual field and
CC eventually central vision as well. {ECO:0000269|PubMed:16199541,
CC ECO:0000269|PubMed:22956603}. Note=The disease is caused by variants
CC affecting the gene represented in this entry.
CC -!- DISEASE: Cone-rod dystrophy 10 (CORD10) [MIM:610283]: An inherited
CC retinal dystrophy characterized by retinal pigment deposits visible on
CC fundus examination, predominantly in the macular region, and initial
CC loss of cone photoreceptors followed by rod degeneration. This leads to
CC decreased visual acuity and sensitivity in the central visual field,
CC followed by loss of peripheral vision. Severe loss of vision occurs
CC earlier than in retinitis pigmentosa, due to cone photoreceptors
CC degenerating at a higher rate than rod photoreceptors.
CC {ECO:0000269|PubMed:16199541}. Note=The disease is caused by variants
CC affecting the gene represented in this entry.
CC -!- SIMILARITY: Belongs to the semaphorin family. {ECO:0000305}.
CC -!- CAUTION: Variant Gln-713 was originally reported as mutation causing
CC retinitis pigmentosa (PubMed:16199541). Subsequently, it has been shown
CC to be a likely benign variant (PubMed:22956603, PubMed:28805479).
CC {ECO:0000269|PubMed:16199541, ECO:0000269|PubMed:22956603,
CC ECO:0000269|PubMed:28805479}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AB029394; BAB20087.1; -; mRNA.
DR EMBL; AY358531; AAQ88895.1; -; mRNA.
DR EMBL; AK091127; BAG52288.1; -; mRNA.
DR EMBL; AK315547; BAG37925.1; -; mRNA.
DR EMBL; AL135927; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; BC020974; AAH20974.1; -; mRNA.
DR CCDS; CCDS1132.1; -. [Q9H3S1-1]
DR CCDS; CCDS53378.1; -. [Q9H3S1-2]
DR RefSeq; NP_001180229.1; NM_001193300.1. [Q9H3S1-1]
DR RefSeq; NP_001180230.1; NM_001193301.1. [Q9H3S1-1]
DR RefSeq; NP_001180231.1; NM_001193302.1. [Q9H3S1-2]
DR RefSeq; NP_071762.2; NM_022367.3. [Q9H3S1-1]
DR RefSeq; XP_011508174.1; XM_011509872.2. [Q9H3S1-1]
DR RefSeq; XP_011508175.1; XM_011509873.2.
DR RefSeq; XP_016857545.1; XM_017002056.1.
DR AlphaFoldDB; Q9H3S1; -.
DR SMR; Q9H3S1; -.
DR BioGRID; 122108; 13.
DR CORUM; Q9H3S1; -.
DR IntAct; Q9H3S1; 5.
DR MINT; Q9H3S1; -.
DR STRING; 9606.ENSP00000357268; -.
DR GlyGen; Q9H3S1; 4 sites.
DR iPTMnet; Q9H3S1; -.
DR PhosphoSitePlus; Q9H3S1; -.
DR BioMuta; SEMA4A; -.
DR DMDM; 29840871; -.
DR EPD; Q9H3S1; -.
DR jPOST; Q9H3S1; -.
DR MassIVE; Q9H3S1; -.
DR MaxQB; Q9H3S1; -.
DR PaxDb; Q9H3S1; -.
DR PeptideAtlas; Q9H3S1; -.
DR PRIDE; Q9H3S1; -.
DR ProteomicsDB; 64964; -.
DR ProteomicsDB; 80746; -. [Q9H3S1-1]
DR Antibodypedia; 20428; 350 antibodies from 33 providers.
DR DNASU; 64218; -.
DR Ensembl; ENST00000355014.6; ENSP00000347117.2; ENSG00000196189.14. [Q9H3S1-1]
DR Ensembl; ENST00000368282.1; ENSP00000357265.1; ENSG00000196189.14. [Q9H3S1-1]
DR Ensembl; ENST00000368284.5; ENSP00000357267.1; ENSG00000196189.14. [Q9H3S1-2]
DR Ensembl; ENST00000368285.8; ENSP00000357268.3; ENSG00000196189.14. [Q9H3S1-1]
DR GeneID; 64218; -.
DR KEGG; hsa:64218; -.
DR MANE-Select; ENST00000368285.8; ENSP00000357268.3; NM_022367.4; NP_071762.2.
DR UCSC; uc001fnl.4; human. [Q9H3S1-1]
DR CTD; 64218; -.
DR DisGeNET; 64218; -.
DR GeneCards; SEMA4A; -.
DR GeneReviews; SEMA4A; -.
DR HGNC; HGNC:10729; SEMA4A.
DR HPA; ENSG00000196189; Tissue enhanced (epididymis).
DR MalaCards; SEMA4A; -.
DR MIM; 607292; gene.
DR MIM; 610282; phenotype.
DR MIM; 610283; phenotype.
DR neXtProt; NX_Q9H3S1; -.
DR OpenTargets; ENSG00000196189; -.
DR Orphanet; 1872; Cone rod dystrophy.
DR Orphanet; 440437; Familial colorectal cancer Type X.
DR Orphanet; 791; Retinitis pigmentosa.
DR PharmGKB; PA35651; -.
DR VEuPathDB; HostDB:ENSG00000196189; -.
DR eggNOG; KOG3611; Eukaryota.
DR GeneTree; ENSGT00940000161509; -.
DR InParanoid; Q9H3S1; -.
DR OMA; KYYAGDG; -.
DR OrthoDB; 64683at2759; -.
DR PhylomeDB; Q9H3S1; -.
DR TreeFam; TF316102; -.
DR PathwayCommons; Q9H3S1; -.
DR Reactome; R-HSA-416700; Other semaphorin interactions.
DR SignaLink; Q9H3S1; -.
DR BioGRID-ORCS; 64218; 7 hits in 1067 CRISPR screens.
DR ChiTaRS; SEMA4A; human.
DR GeneWiki; SEMA4A; -.
DR GenomeRNAi; 64218; -.
DR Pharos; Q9H3S1; Tbio.
DR PRO; PR:Q9H3S1; -.
DR Proteomes; UP000005640; Chromosome 1.
DR RNAct; Q9H3S1; protein.
DR Bgee; ENSG00000196189; Expressed in monocyte and 158 other tissues.
DR ExpressionAtlas; Q9H3S1; baseline and differential.
DR Genevisible; Q9H3S1; HS.
DR GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR GO; GO:0045499; F:chemorepellent activity; IBA:GO_Central.
DR GO; GO:0030215; F:semaphorin receptor binding; IBA:GO_Central.
DR GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR GO; GO:0050919; P:negative chemotaxis; IBA:GO_Central.
DR GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
DR GO; GO:0048843; P:negative regulation of axon extension involved in axon guidance; IBA:GO_Central.
DR GO; GO:0001755; P:neural crest cell migration; IBA:GO_Central.
DR GO; GO:0030335; P:positive regulation of cell migration; IBA:GO_Central.
DR GO; GO:1904891; P:positive regulation of excitatory synapse assembly; ISS:UniProtKB.
DR GO; GO:1905704; P:positive regulation of inhibitory synapse assembly; ISS:UniProtKB.
DR GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR GO; GO:0010594; P:regulation of endothelial cell migration; IEA:Ensembl.
DR GO; GO:0071526; P:semaphorin-plexin signaling pathway; IBA:GO_Central.
DR GO; GO:0045063; P:T-helper 1 cell differentiation; IEA:Ensembl.
DR Gene3D; 2.130.10.10; -; 1.
DR InterPro; IPR002165; Plexin_repeat.
DR InterPro; IPR016201; PSI.
DR InterPro; IPR001627; Semap_dom.
DR InterPro; IPR036352; Semap_dom_sf.
DR InterPro; IPR027231; Semaphorin.
DR InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR PANTHER; PTHR11036; PTHR11036; 1.
DR Pfam; PF01437; PSI; 1.
DR Pfam; PF01403; Sema; 1.
DR SMART; SM00423; PSI; 1.
DR SMART; SM00630; Sema; 1.
DR SUPFAM; SSF101912; SSF101912; 1.
DR PROSITE; PS51004; SEMA; 1.
PE 1: Evidence at protein level;
KW Adaptive immunity; Alternative splicing; Angiogenesis; Cell membrane;
KW Cone-rod dystrophy; Developmental protein; Differentiation;
KW Disease variant; Disulfide bond; Glycoprotein; Immunity;
KW Immunoglobulin domain; Membrane; Neurogenesis; Reference proteome;
KW Retinitis pigmentosa; Signal; Transmembrane; Transmembrane helix.
FT SIGNAL 1..32
FT /evidence="ECO:0000255"
FT CHAIN 33..761
FT /note="Semaphorin-4A"
FT /id="PRO_0000032322"
FT TOPO_DOM 33..683
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 684..704
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 705..761
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT DOMAIN 36..494
FT /note="Sema"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT DOMAIN 496..548
FT /note="PSI"
FT DOMAIN 573..631
FT /note="Ig-like C2-type"
FT REGION 722..749
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT CARBOHYD 120
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 135
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 496
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 607
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 113..124
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT DISULFID 142..151
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT DISULFID 269..379
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT DISULFID 293..339
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT DISULFID 497..514
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT DISULFID 506..523
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT DISULFID 580..624
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00352"
FT VAR_SEQ 1..99
FT /note="Missing (in isoform 2)"
FT /evidence="ECO:0000303|PubMed:14702039"
FT /id="VSP_046381"
FT VAR_SEQ 122..154
FT /note="Missing (in isoform 2)"
FT /evidence="ECO:0000303|PubMed:14702039"
FT /id="VSP_046382"
FT VARIANT 345
FT /note="D -> H (in RP35 and CORD10; heterozygous compound
FT with C-350; loss of localization to cell membrane;
FT dbSNP:rs267607033)"
FT /evidence="ECO:0000269|PubMed:16199541,
FT ECO:0000269|PubMed:22956603"
FT /id="VAR_028322"
FT VARIANT 350
FT /note="F -> C (in RP35 and CORD10; heterozygous compound
FT with H-345; loss of localization to cell membrane;
FT dbSNP:rs267607034)"
FT /evidence="ECO:0000269|PubMed:16199541,
FT ECO:0000269|PubMed:22956603"
FT /id="VAR_028323"
FT VARIANT 510
FT /note="R -> Q (in dbSNP:rs2075164)"
FT /id="VAR_028324"
FT VARIANT 713
FT /note="R -> Q (originally reported as mutation causing
FT retinitis pigmentosa; no effect on localization to cell
FT membrane; dbSNP:rs41265017)"
FT /evidence="ECO:0000269|PubMed:16199541,
FT ECO:0000269|PubMed:22956603, ECO:0000269|PubMed:28805479"
FT /id="VAR_028325"
FT CONFLICT 293..328
FT /note="CTQPGQLPFNVIRHAVLLPADSPTAPHIYAVFTSQW -> SAPSRGSCPSTS
FT SATRSCSPPILPQLPTSTQSSPPSG (in Ref. 1)"
FT /evidence="ECO:0000305"
FT CONFLICT 354
FT /note="Y -> F (in Ref. 1; BAB20087)"
FT /evidence="ECO:0000305"
FT CONFLICT 641
FT /note="D -> G (in Ref. 3; BAG52288)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 761 AA; 83574 MW; 5BCB889AA32A2BB3 CRC64;
MALPALGLDP WSLLGLFLFQ LLQLLLPTTT AGGGGQGPMP RVRYYAGDER RALSFFHQKG
LQDFDTLLLS GDGNTLYVGA REAILALDIQ DPGVPRLKNM IPWPASDRKK SECAFKKKSN
ETQCFNFIRV LVSYNVTHLY TCGTFAFSPA CTFIELQDSY LLPISEDKVM EGKGQSPFDP
AHKHTAVLVD GMLYSGTMNN FLGSEPILMR TLGSQPVLKT DNFLRWLHHD ASFVAAIPST
QVVYFFFEET ASEFDFFERL HTSRVARVCK NDVGGEKLLQ KKWTTFLKAQ LLCTQPGQLP
FNVIRHAVLL PADSPTAPHI YAVFTSQWQV GGTRSSAVCA FSLLDIERVF KGKYKELNKE
TSRWTTYRGP ETNPRPGSCS VGPSSDKALT FMKDHFLMDE QVVGTPLLVK SGVEYTRLAV
ETAQGLDGHS HLVMYLGTTT GSLHKAVVSG DSSAHLVEEI QLFPDPEPVR NLQLAPTQGA
VFVGFSGGVW RVPRANCSVY ESCVDCVLAR DPHCAWDPES RTCCLLSAPN LNSWKQDMER
GNPEWACASG PMSRSLRPQS RPQIIKEVLA VPNSILELPC PHLSALASYY WSHGPAAVPE
ASSTVYNGSL LLIVQDGVGG LYQCWATENG FSYPVISYWV DSQDQTLALD PELAGIPREH
VKVPLTRVSG GAALAAQQSY WPHFVTVTVL FALVLSGALI ILVASPLRAL RARGKVQGCE
TLRPGEKAPL SREQHLQSPK ECRTSASDVD ADNNCLGTEV A
